Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance

The emigration of circulating leukocytes into tissues is a characteristic of the inflammatory response. The extravasation of leukocytes and some tumor cells is controlled by the expression of cell sudice adhesion molecules on both the circulating cells and on the vascular endothelium.' We have produced monoclonal antibodies that bind to cytokine-activated human umbilical vein endothelial cells, and which can block the adhesion of leukocytes to the endothelium.2 These antibodies have been used to expression clone the adhesion molecules ICAM-1, VCAM-1 and E-Selectin (ELAM-1) (see TABLE 1). Functional studies using blocking monoclonal antibodies and mammalian cells stably transkcted with these adhesins have revealed their binding specificities. ICAM-1 will bind cells expressing the 62 integrins, or CD43, including lymphocytes, granulocytes, and m~nocy tes .~~ . " VCAM-1 will bind cells expressing the B1 integrin VLA4 (bla4), including lymphocytes, eosinophils, basophils, and m0nocytes.~-12 E-Selectin will bind granulocytes, monocytes and a subset of memory T cells (CLA+).l3-15 The identity of the physiological hgand(s) for E-Selectin on these cells is unclear; however, hcosylation and sialylation are thought to be important for binding. 16117 We have used monoclonal antibodies to investigte the expression ofadhesion molecules on endothelium and other tissues, in a range of inflammatory diseases. Reports

[1]  W. Hahn,et al.  CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1 , 1991, Nature.

[2]  C. Smith,et al.  Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. , 1991, The Journal of clinical investigation.

[3]  R. Rothlein,et al.  Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. , 1991, Cancer research.

[4]  S. Hakomori,et al.  CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Makgoba,et al.  Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders , 1991, The Lancet.

[6]  L. Needham,et al.  Structural and functional studies of the endothelial activation antigen endothelial leucocyte adhesion molecule-1 using a panel of monoclonal antibodies. , 1991, Journal of immunology.

[7]  S. Bixler,et al.  Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1. , 1991, Journal of immunology.

[8]  Timothy A. Springer,et al.  Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation , 1991, Cell.

[9]  F. Luscinskas,et al.  Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules , 1991, The Journal of experimental medicine.

[10]  S. Wright,et al.  Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils , 1991, The Journal of experimental medicine.

[11]  A. Wardlaw,et al.  Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. , 1991, Journal of immunology.

[12]  P. Norris,et al.  The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. , 1991, The Journal of investigative dermatology.

[13]  R. Cotran,et al.  Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions. , 1991, The Journal of clinical investigation.

[14]  P. Moy,et al.  Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1). , 1991, The Journal of biological chemistry.

[15]  W. Newman,et al.  Activation-independent binding of human memory T cells to adhesion molecule ELAM-1 , 1991, Nature.

[16]  L. Picker,et al.  ELAM-1 is an adhesion molecule for skin-homing T cells , 1991, Nature.

[17]  S. Watson,et al.  Neutrophil influx into an inflammatory site inhibited by a soluble homing receptor–IgG chimaera , 1991, Nature.

[18]  G. Rice,et al.  Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. , 1991, The American journal of pathology.

[19]  P. Robbins,et al.  Carbohydrate ligands of the LEC cell adhesion molecules , 1990, Cell.

[20]  S. Uccini,et al.  Cytokine Production (IL-1α, IL-1β, and TNFα) and Endothelial Cell Activation (ELAM-1 and HLA-DR) in Reactive Lymphadenitis, Hodgkin's Disease, and in Non-Hodgkin's Lymphomas: An Immunocytochemical Study , 1990 .

[21]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[22]  R. Sobel,et al.  Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. , 1990, The American journal of pathology.

[23]  G. Rice,et al.  Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism , 1990, The Journal of experimental medicine.

[24]  D. Staunton,et al.  A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection , 1990, Nature.

[25]  M. Elices,et al.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.

[26]  R. Rothlein,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.

[27]  D. Adams Induction of intercellular adesion molecule 1 (ICAM-1) on liver allografts during rejection , 1990 .

[28]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.

[29]  G. Rice,et al.  An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. , 1989, Science.

[30]  J. Neuberger,et al.  INTERCELLULAR ADHESION MOLECULE 1 ON LIVER ALLOGRAFTS DURING REJECTION , 1989, The Lancet.

[31]  G. Russ,et al.  Tubular expression of intercellular adhesion molecule-1 during renal allograft rejection. , 1989, Transplantation.

[32]  R. Cook,et al.  Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation , 1989, Cell.

[33]  B. Seed,et al.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.

[34]  B. Seed,et al.  ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM , 1988, Nature.

[35]  Timothy A. Springer,et al.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) , 1987, Cell.

[36]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.